08/27/2025

FDA Approves Coronavirus Vaccines for ‘Higher Risk’ People

The narrowed approval marks a shift from past recommendations

The Food and Drug Administration (FDA) signed off Wednesday on coronavirus (COVID-19) vaccines for those considered higher risk, narrowing approval for shots once routinely provided to nearly all Americans.

The agency cleared shots manufactured by Pfizer, Moderna and Novavax. Companies were working to reformulate their vaccines to better target new strains of the virus. The move comes as the country is in the midst of a midsummer wave of coronavirus cases.

The FDA limited approval of the new vaccines to those at “higher risk,” Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. said in an  X post announcing the approvals.

Please select this link to read the complete article from The Washington Post.